Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Antheia, Inc. currently manages 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed among 3 distinct examiners and several distinct art units. This distribution indicates that the company's patenting efforts are spread across different technical or administrative divisions within the USPTO. With multiple distinct examiners assigned to the pending actions, the company faces a diverse set of perspectives and requirements during the prosecution process.
The busiest examiner, EIX, EMILY FAY, is responsible for 1 busiest examiner pending office action. This is one of the 3 total pending office actions currently active for the company. Because the pending actions are handled by different examiners, the company must manage multiple separate examiner relationships. The involvement of distinct art units further suggests that the prosecution strategy must account for varying standards across these divisions. This structure indicates a portfolio that is highly distributed, with each active matter being handled in a unique administrative environment. Practitioners should tailor their approach to the 1 busiest examiner pending action while maintaining consistency across the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| Double-patenting + other | 1 (33%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EIX, EMILY FAY | 1 | 45.5% | +78.3% |
| STEADMAN, DAVID J | 1 | 57.7% | +29.6% |
| MOAZZAMI, NAGHMEH NINA | 1 | 72.0% | +49.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18145608 | NEOPINONE ISOMERASE AND METHODS OF USING | STEADMAN, DAVID J | 38d overdue |
| 18253585 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | EIX, EMILY FAY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18145608 | NEOPINONE ISOMERASE AND METHODS OF USING | STEADMAN, DAVID J | 38d overdue |
| 18253585 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | EIX, EMILY FAY | — |
| 17486274 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | MOAZZAMI, NAGHMEH NINA | — |
| Art Unit | Apps |
|---|---|
| 1653 | 1 |
| 1656 | 1 |
| 1652 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18253585 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | EIX, EMILY FAY | 1653 | §102§112 | Non-Final OA | — | Pending | May 18, 2023 |
| 18145608 | NEOPINONE ISOMERASE AND METHODS OF USING | STEADMAN, DAVID J | 1656 | §101§102§112DP | Non-Final OA | 38d overdue | Pending | Dec 22, 2022 |
| 17486274 | METHODS OF IMPROVING PRODUCTION OF MORPHINAN ALKALOIDS AND DERIVATIVES | MOAZZAMI, NAGHMEH NINA | 1652 | §103DP | Final Rejection | — | Pending | Sep 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial